Drug details

Ruconest (c1 esterase inhibitor [recombinant] intravenous injection)

type of Immunomodulators

Ruconest (C1 esterase inhibitor [recombinant]) Intravenous Injection is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

This drug may have the following side effects:
  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • lightheadedness,
  • confusion,
  • fast heartbeats,
  • wheezing,
  • chest tightness,
  • blue lips or gums,
  • pain, swelling, warmth, or redness in an arm or leg,
  • sudden severe headache,
  • fast heart rate
  • problems with vision, speech, or balance,
  • chest pain while taking deep breaths, and
  • sudden numbness or weakness (on one side of the body),
The following drugs are related to Ruconest, either as a replacement or used together:
  • Berinert ([c1 esterase inhibitor (human)] freeze-dried powder)
  • Orladeyo (berotralstat capsules)
  • Cinryze (c1 esterase inhibitor [human] freeze dried powder)
  • Haegarda (c1 esterase inhibitor subcutaneous [human] injection)
  • Kalbitor (ecallantide injection)
  • Firazyr (icatibant injection for subcutaneous administration)
  • Sajazir (icatibant injection, for subcutaneous use)
  • Takhzyro (lanadelumab-flyo injection)